Lorenzen, S., Goetze, T. O., Thuss-Patience, P. C., Riera-Knorrenschild, J., Goekkurt, E., Dechow, T. N., Ettrich, T. J., Hofheinz, R. D., Luley, K. B., Pink, D., Lindig, U., Folprecht, G., Schuch, G., Bitzer, M., Heinemann, V., Angermeier, S., Bolling, C., Loose, M., Junge, S., Pauligk, C., Al-Batran, S. (2026). Author Correction: First-line modified FOLFOX plus/minus nivolumab and Ipilimumab or FLOT plus nivolumab in advanced gastroesophageal adenocarcinoma: a phase II multi-cohort IKF-AIO-MOONLIGHT trial. Nature Communications. https://doi.org/10.1038/s41467-026-72255-5